GYNOFORT - DRUG OF CHOICE FOR THE TREATMENT OF UNCOMPLICATED VULVOVAGINAL CANDIDIASIS


Cite item

Full Text

Abstract

The article presents the data for the common infection of the womans genital tract - vulvovaginal candidiasis (etiology, risk factors, route of infection, diagnosis and treatment). Butokonazole nitrate (Ginofort) in the form of cream for intravaginal use is recommended as the drug of choice for the treatment of uncomplicated vulvovaginal candidiasis.

About the authors

Yuliya Vladimirovna Saprykina

Yu V Saprykina

References

  1. Тихомиров А.Л., Олейник Ч.Г. Современное лечение кандидозного вульвовагинита // РМЖ. 2001. № 19. С. 227-32.
  2. Прилепская В.Н., Байрамова Г.Р. Вульвовагинальный кандидоз. Клиника, диагностика // РМЖ. 2011. Т. 19. № 2.
  3. Eschenbach DA. Chronic vulvovaginal candidiasis. N Engl J Med 2004;351(9):851-52.
  4. Patel DA, Gillespie B, Sobel JD, et al. Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study. Am J Obstet Gynecol 2004;190:644-53.
  5. Pappas PG, Cauffman CA, Andes D, et al. Clinical practice Guidelines for the management of Candidiasis: 2009 update by the Infectionis Diseases Sosiety of America. Clinical Infectionis Diseases 2009;48:503-35.
  6. Weinstein L, Henzel MR, Tsina IW. Vaginal retention of 2 % butoconazol nitrate cream: comparison of a standard and a sustained-release preparation. Clin Ther 1994;16:930-34.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011 Bionika Media